Your browser doesn't support javascript.
loading
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.
Narhi, L; Wood, S J; Steavenson, S; Jiang, Y; Wu, G M; Anafi, D; Kaufman, S A; Martin, F; Sitney, K; Denis, P; Louis, J C; Wypych, J; Biere, A L; Citron, M.
Afiliação
  • Narhi L; Amgen, Inc., Thousand Oaks, California 91320-1789, USA.
J Biol Chem ; 274(14): 9843-6, 1999 Apr 02.
Article em En | MEDLINE | ID: mdl-10092675
ABSTRACT
Parkinson's disease (PD) is a neurodegenerative disorder that is pathologically characterized by the presence of intracytoplasmic Lewy bodies, the major component of which are filaments consisting of alpha-synuclein. Two recently identified point mutations in alpha-synuclein are the only known genetic causes of PD, but their pathogenic mechanism is not understood. Here we show that both wild type and mutant alpha-synuclein form insoluble fibrillar aggregates with antiparallel beta-sheet structure upon incubation at physiological temperature in vitro. Importantly, aggregate formation is accelerated by both PD-linked mutations. Under the experimental conditions, the lag time for the formation of precipitable aggregates is about 280 h for the wild type protein, 180 h for the A30P mutant, and only 100 h for the A53T mutant protein. These data suggest that the formation of alpha-synuclein aggregates could be a critical step in PD pathogenesis, which is accelerated by the PD-linked mutations.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fosfoproteínas / Mutação / Proteínas do Tecido Nervoso Limite: Humans Idioma: En Ano de publicação: 1999 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fosfoproteínas / Mutação / Proteínas do Tecido Nervoso Limite: Humans Idioma: En Ano de publicação: 1999 Tipo de documento: Article